High‐grade B‐cell lymphoma developed during the treatment of chronic myeloid leukemia with bosutinib by Teruhito Takakuwa, Ryota Sakai, Shiro Koh, Hiroshi Okamura, Satoru Nanno, Yasuhiro Nakashima, Takahiko Nakane, Hideo Koh, Masayuki Hino, Hirohisa Nakamae

Subjects: Get full text

Factors associated with achievement and durability of cytogenetic response in patients with chronic myeloid leukemia treated with imatinib by Ćojbašić Irena, Mačukanović-Golubović Lana

“…Imatinib mesylate, a selective Bcr-Abl tyrosine kinase inhibitor, has revolutionized the treatment of Bcr-Abl positive chronic myeloid leukemia and become the standard of care for this disease. …”
Get full text

The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era by Ilana Zalcberg Renault, Vanesa Scholl, Rocio Hassan, Paola Capelleti, Marcos de Lima, Jorge Cortes

“…Tyrosine kinase inhibitors have changed the management and outcomes of chronic myeloid leukemia patients. Quantitative polymerase chain reaction is used to monitor molecular responses to tyrosine kinase inhibitors. …”
Get full text

IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia by Jani Huuhtanen, Mette Ilander, Bhagwan Yadav, Olli M.J. Dufva, Hanna Lähteenmäki, Tiina Kasanen, Jay Klievink, Ulla Olsson-Strömberg, Jesper Stentoft, Johan Richter, Perttu Koskenvesa, Martin Höglund, Stina Söderlund, Arta Dreimane, Kimmo Porkka, Tobias Gedde-Dahl, Björn T. Gjertsen, Leif Stenke, Kristina Myhr-Eriksson, Berit Markevärn, Anna Lübking, Andreja Dimitrijevic, Lene Udby, Ole Weis Bjerrum, Henrik Hjorth-Hansen, Satu Mustjoki

“…In chronic myeloid leukemia (CML), combination therapies with tyrosine kinase inhibitors (TKIs) aim to improve the achievement of deep molecular remission that would allow therapy discontinuation. …”
Get full text

A case of double leukemia: chronic myeloid leukemia intolerant to imatinib and chronic lymphocytic leukemia by Miriana Rocchi

Subjects: “…Chronic myeloid leukemia…”
Get full text

Treatment-Free Remission in Chronic Myeloid Leukemia and New Approaches by Targeting Leukemia Stem Cells by Yilin Chen, Jing Zou, Fanjun Cheng, Weiming Li

Subjects: “…chronic myeloid leukemia…”
Get full text

P659: BUPARLISIB A PROMISING THERAPEUTIC APPROACH IN CHRONIC MYELOID LEUKEMIA RESISTANT TO IMATINIB by Raquel Alves, Inês Silva, Maria Inês Costa, Beatriz Lapa, Joana Jorge, Ana Cristina Gonçalves, Ana Bela Sarmento-Ribeiro

Get full text

Combination of two but not three current targeted drugs can improve therapy of chronic myeloid leukemia. by Natalia L Komarova, Allen A Katouli, Dominik Wodarz

“…Chronic myeloid leukemia (CML) is a cancer of the hematopoietic system and has been treated with the drug Imatinib relatively successfully. …”
Get full text

Imatinib Efficacy, Safety and Resistance in Iranian Patients with Chronic Myeloid Leukemia: A Review of Literature by Asiyeh Amouei, Nesa Daeian, Seyedeh Sana Khezrnia, Ava Mansouri, Molouk Hadjibabaie

Subjects: “…Imatinib mesylate; Treatment outcome; Antineoplastic agent resistance; Chronic myeloid leukemia; Adverse drug event…”
Get full text

CD26+ LEUKEMIC STEM CELLS IDENTIFICATION AS A TOOL FOR CHRONIC MYELOID LEUKEMIA DIAGNOSIS by F.M. Furtado, C.S. Nobre, F.O. Resende, A.C.M. Castro, L.F.R. Velasco, A.L. Barbosa, P. Trevisan, L.F. Abdalla, R.H. Jacomo

Get full text

Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia by Eaves Connie J, Jiang Xiaoyan, Zhao Yun, Rogers Sally L, Mager Dixie L, Rouhi Arefeh

“…<p>Abstract</p> <p>Background</p> <p>Expression levels of the cell surface glycoprotein, CD7, and the serine protease, elastase 2 (ELA2), in the leukemic cells of patients with chronic myeloid leukemia (CML) have been associated with clinical outcome. …”
Get full text

Investigating the p53 Codon 72 Polymorphism in Patients with Chronic Myeloid Leukemia in Isfahan, Iran by Mehdi Nikbakht-Dastjerdi, Fatemehsadat Mirabutalebi, Zeinab Ebrahimi

Subjects: “…Chronic myeloid leukemia…”
Get full text

P656: NOVEL THIAZOLIDINEDIONE WITH HDAC INHIBITING PROPERTIES OPTIMIZED FOR CHRONIC MYELOID LEUKEMIA TREATMENT by Anna Rams, Paulina Laskowska, Adrianna Cieloch, Kalpana Tilekar, Neha Upadhyay, C.S. Ramaa, Piotr Mrowka, Eliza Głodkowska-Mrówka

Get full text

P693: DIAGNOSTIC ROLE OF CD26+ LEUKEMIC STEM CELLS IN CHRONIC MYELOID LEUKEMIA by S. Tiwari, J. Dass, G. Vishwanathan, R. Dhawan, M. Agarwal, P. Kumar, T. Seth, S. Tyagi, M. Mahapatra

Get full text

Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center by Ariella Cássia de Moura, Márcia Torresan Delamain, Gislaine Borba Oliveira Duarte, Irene Lorand-Metze, Cármino Antônio de Souza, Kátia Borgia Barbosa Pagnano

“…We analyzed the management and outcomes of pregnancies of patients with chronic myeloid leukemia at a single center over fifteen years. …”
Get full text

Evaluation of early hospital discharge after allogeneic bone marrow transplantation for chronic myeloid leukemia by José Eduardo Nicolau, Leila Maria Magalhães Pessoa de Melo, Daniel Sturaro, Rosaura Saboya, Frederico Luiz Dulley

Subjects: “…Chronic myeloid leukemia…”
Get full text

AVASCULAR NECROSIS IN CHRONIC MYELOID LEUKEMIA: A REVIEW OF PATHOPHYSIOLOGY, PATIENTS’ CHARACTERISTICS, AND CLINICAL OUTCOMES by Abdulrahman Al-Mashdali, Husam Al-Dubai, Mohamed Yassin

“…Objective: The exact incidence of avascular necrosis (AVN) in chronic myeloid leukemia (CML) is still unknown as the number of cases is limited. …”
Get full text

Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors by Jee Hyun Kong, Elliott F. Winton, Leonard T. Heffner, Manila Gaddh, Brittany Hill, Jessica Neely, Angela Hatcher, Meena Joseph, Martha Arellano, Fuad El-Rassi, Audrey Kim, Jean Hanna Khoury, Vamsi K. Kota

Subjects: “…chronic myeloid leukemia…”
Get full text

Isolated central nervous system blast crisis in a case of chronic myeloid leukemia on dasatinib by P K Kiran, Girish V Badarke, C N Suresh, B J Srinivas, Radheshyam Naik

Get full text

Frequency of BCR-ABL 1 Fusion Transcripts Variants in Chronic Myeloid Leukemia Algerian patients by Mourad NACHI, Ibtissem KIHEL, Badra ENTASOLTAN, Karima TAIBI, Djaouad GUELLA, Amine ABED, Yasmine BOUKHATMI, Mohamed-Amine BEKADJA

Subjects: “…Chronic Myeloid Leukemia…”
Get full text